SCHEMBL20209551

SCHEMBL20209551

C=CC(=C)Nc1ccc(N2CCCCC2)nc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNQ3 O43525 1/20 0.50
▸ KCNQ2 O43526 1/20 0.50
▸ TRPV1 Q8NER1 1/20 0.46
▸ UBE2T Q9NPD8 1/20 0.43
▸ MAPT P10636 8/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ BTK Q06187 1/20 0.43
▸ KCNH2 Q12809 1/20 0.43
▸ RAB9A P51151 3/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ ALOX12 P18054 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ CNR2 P34972 2/20 0.41
▸ CNR1 P21554 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22664052 0.86 KCNQ3 (0.54) KCNQ3KCNQ2TRPV1MAPTKDM4E
SCHEMBL24645772 0.78 MAPT (0.67) KCNQ3KCNQ2TRPV1MAPTKDM4E
SCHEMBL4969527 0.77 KCNQ3 (0.60) KCNQ3KCNQ2TRPV1MAPTKDM4E
SCHEMBL20209108 0.76 GFER (0.58) MAPTKDM4ERAB9AL3MBTL1ALDH1A1
SCHEMBL4082931 0.76 KCNQ3 (0.48) KCNQ3KCNQ2TRPV1UBE2TMAPT
Hydrochloric Acid SCHEMBL23246065 0.75 UBE2T (0.59) KCNQ3KCNQ2TRPV1UBE2TMAPT
Hydrochloric Acid SCHEMBL29618429 0.75 UBE2T (0.59) KCNQ3KCNQ2TRPV1UBE2TMAPT
SCHEMBL13006763 0.74 MAPT (0.49) KCNQ3KCNQ2TRPV1UBE2TMAPT
SCHEMBL27961413 0.74 KCNQ3 (0.56) KCNQ3KCNQ2TRPV1MAPTKDM4E
SCHEMBL14504200 0.73 KCNQ3 (0.44) KCNQ3KCNQ2TRPV1UBE2TMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018098361-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASE 12 (CDK12) AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2018-05-31 — — WO disclosed
Send feedback